Ocular Immunology and Angiogenesis Laboratory at the 91ɫƵ
The OIAL, led by Dr. Chaurasia, focuses on the Molecular Basis of Eye Diseases, aiming to establish a cutting-edge multidisciplinary research program dedicated to identifying and validating new biomarkers and therapeutic targets for Next-Generation Precision Medicine to manage Ocular Fibrotic and Angiogenic Diseases (OFADs). Dr. Chaurasia brings extensive expertise in basic and translational vision sciences, demonstrated by his authorship of over 125 peer-reviewed research articles and more than 150 scientific abstracts and presentations at national and international levels.
Molecular Basis of Eye Diseases
OIAL by the Numbers
Funding
We are fortunate to have a diverse array of funding sources for our research at the Eye Institute. We would like to acknowledge the National Institute of Health (NIH), the National Eye Institute (NEI), Children's Wisconsin, and ARVO Foundation for Eye Research for their long-term support of our research projects. We also gratefully thank the many other local and national foundations who have made contributions to advance our mission. Finally, we thank our patients for their philanthropic donations, which provide especially vital support for new projects and continued innovation.
Contact Us
Rm 816/819/820
925 N. 87th St.
Milwaukee, WI 53226